Approval · Notice of Compliance 7910 · 2006
DIPENTUM: Notice of Compliance 7910
Issued April 26, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7910
- Date
- April 26, 2006
- Company
- Lundbeck Canada IncSt-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Lower gastrointestinal anti-inflammatory
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DIPENTUM | 02063808 | Marketed |
Medicinal ingredients
- OLSALAZINE SODIUM 250 MG per CAP